XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Revenue $ 416,861 $ 346,974 $ 1,212,396 $ 963,238
Cost of revenue [1] 79,462 70,226 237,930 197,863
Gross profit 337,399 276,748 974,466 765,375
Operating expenses:        
Research and development [1] 105,203 92,112 323,819 248,721
Sales and marketing [1] 211,593 172,828 622,413 495,596
General and administrative [1] 76,030 50,716 236,778 139,667
Total operating expenses [1] 392,826 315,656 1,183,010 883,984
Operating loss (55,427) (38,908) (208,544) (118,609)
Other income (expense), net:        
Interest expense (3,131) (14,762) (9,373) (43,768)
Interest and other income (expense), net 2,913 2,386 5,845 8,430
Total other income (expense), net (218) (12,376) (3,528) (35,338)
Loss before provision for income taxes (55,645) (51,284) (212,072) (153,947)
Provision for income taxes 3,448 3,133 9,049 7,842
Net loss $ (59,093) $ (54,417) $ (221,121) $ (161,789)
Net loss per share, basic (in usd per share) $ (0.48) $ (0.45) $ (1.80) $ (1.36)
Net loss per share, diluted (in usd per share) $ (0.48) $ (0.45) $ (1.80) $ (1.36)
Weighted-average shares used to compute net loss per share, basic (in shares) 123,576 120,164 122,799 119,050
Weighted-average shares used to compute net loss per share, diluted (in shares) 123,576 120,164 122,799 119,050
[1] Includes share-based compensation expense as follows:
 
 Three Months Ended
September 30,
Nine Months Ended
September 30,
2022202120222021
Cost of revenue$7,053 $5,343 $20,212 $15,047 
Research and development22,885 17,189 62,654 49,886 
Sales and marketing35,014 24,915 92,934 72,648 
General and administrative15,007 12,086 41,456 31,020